'Painless' eye drops tested to save sight in kids with brain tumors
Disease control
Ongoing
This study is testing a new type of eye drop called CHF6467, a 'painless' nerve growth factor, to see if it can protect and improve vision in children and young adults with optic pathway glioma (OPG), a type of brain tumor that often causes vision loss. The trial will compare the…
Phase: PHASE2 • Sponsor: Benedetto Falsini • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC